Vaccines for Enteric Disease

Conference Chairs:

Ann-Mari Svennerholm (Gothenburg University, Gothenburg, Sweden)
Jan Holmgren (Gothenburg University, Gothenburg, Sweden)

Panel Members:

Duncan Steele (Bill & Melinda Gates Foundation, Seattle, Washington, USA)
Annelies Wilder-Smith (World Health Organisation, Geneva, Switzerland)
Myron M. Levine (University of Maryland, Baltimore, Maryland, USA)
John D. Clemens (University of California, Los Angeles, California, USA)
Kevin Killeen (Matrivax Corporation, Boston, USA)
Harry B. Greenberg (Stanford University, Stanford, California, USA)
Umesh Parashar (CDC, Atlanta, USA)
David Sack (Johns Hopkins University, Baltimore, Maryland, USA)
Armelle Phalipon (Pasteur Institute, Paris, France)
Daniel Cohen (Tel Aviv University, Tel Aviv, Israel)
Richard Walker (PATH, Washington DC, USA)
Shahida Baqar (NIAID/NIH, Bethesda, Maryland, USA)
K. Zaman (icddrb, Dhaka, Bangladesh)
Elizabeth Norton (Tulane University, New Orleans, Louisiana, USA)
Eileen M Barry (University of Maryland, Baltimore, Maryland, USA)
Lou Bourgeois (Johns Hopkins University, Baltimore, Maryland, USA)
Firdausi Qadri (icddrb, Dhaka, Bangladesh)
Timo Vesikari (Nordic Research Network Oy, Tampere, Finland)
Bjorn Sjostrand (Scandinavian Biopharma, Solna, Sweden)

VED 2025 will focus on:

• Epidemiology
• Virology
• Microbiology
• Immunology
• Mechanisms of Pathophysiology
• Immune Responses to Enteric Pathogens
• New Vaccine Vectors Enteric Vaccine Adjuvants
• Animal Models Studies
• Animal Disease
• Vaccine Delivery Systems
• Enteric Vaccine Field Testing Salmonella Typhi and Live Vectors
• Shigella
• Cholera
• Escherchia Coli (enterotoxigenic)
• Rotavirus (Rotarix® vaccine and RotaTeq® vaccine)
• Live versus Killed Vaccines
• Etec
• Campylobacter
• Heliobacter Pylori
• Chlostridium Difficile
• Entamoeba Histolytica
• Protazoa Viral Vaccines (Human Caliciviruses, Rotavirus, Norwalk-like Viruses, Coronaviruses, Adenovirus, Astrovirus)
• Mucosal Immunization
• mRNA/DNA Vaccines Edible Plant Vaccines
• Transcutaneous Vaccines
• Food Safety Vaccines
• Vaccine Production Issues
• Enteric Vaccine Construction and Design
• mRNA/DNA Vaccines
• Delivery of Transgenes by Enteric Vaccines
• Problems with and usage of enteric vaccines in developing countries
• Specific treatments against acute diarrhea
• New Developments and Initiatives with enteric vaccines

VED 2025 will be a major opportunity to:

• Re-evaluate the diarrheal disease burden both in the industrialized and developing worlds.
• Discuss which diseases, depending on the area, would require an immunization strategy and if eradication or control of the selected disease is achievable by a vaccine.
• Discuss the state-of-the-art vaccine candidates currently available.
• Discuss obstacles to obtaining institutional and industrial support for these vaccines.
• Review of studies in developing countries.
• Air views on the lack of facilities for enteric vaccine trials.
• Discuss the distribution of vaccines and implementation policy in the developing world.